Title (en)

MULTI-MODAL STIMULATION FOR TREATING TREMOR

Title (de)

MULTIMODALE STIMULATION ZUR BEHANDLUNG VON TREMOR

Title (fr)

STIMULATION MULTIMODALE DE TRAITEMENT DES TREMBLEMENTS

Publication

EP 3813647 A4 20220309 (EN)

Application

EP 19825339 A 20190626

Priority

• US 201816020876 A 20180627
• US 2019039193 W 20190626

Abstract (en)

[origin: WO2020006048A1] A peripheral nerve stimulator to stimulate a peripheral nerve to treat essential tremor and other movement disorders, as well as overactive bladder, cardiac dysfunction and neurotransmitter dysfunction is provided. The peripheral nerve stimulator can be a noninvasive surface stimulator to provide multi-modal optimized therapy. Stimulation can be vibrational, electromechanical, thermal, radiant, electrical, magnetic, electromagnetic, light, mechanical, chemical, thermal, ultrasonic, radiofrequency (RF), acoustic, infrared, ultraviolet, x-ray, and/or microwave. Stimulation can be delivered using an open loop system and/or a closed loop system with feedback. Stimulation can be to one site or multiple sites.

IPC 8 full level

A61B 5/01 (2006.01); A61B 5/00 (2006.01); A61B 5/024 (2006.01); A61B 5/0533 (2021.01); A61B 5/369 (2021.01); A61B 5/389 (2021.01); A61F 7/00 (2006.01); A61H 23/02 (2006.01); A61H 39/04 (2006.01); A61N 1/04 (2006.01); A61N 1/05 (2006.01); A61N 1/36 (2006.01); A61N 2/00 (2006.01); A61N 2/02 (2006.01); A61N 5/02 (2006.01); A61N 5/06 (2006.01); A61N 7/00 (2006.01)

CPC (source: EP)

A61B 5/01 (2013.01); A61B 5/02405 (2013.01); A61B 5/02416 (2013.01); A61B 5/0533 (2013.01); A61B 5/369 (2021.01); A61B 5/389 (2021.01); A61B 5/4064 (2013.01); A61B 5/4812 (2013.01); A61B 5/6891 (2013.01); A61B 5/7207 (2013.01); A61H 1/00 (2013.01); A61N 1/36031 (2017.07); A61N 2/002 (2013.01); A61N 2/006 (2013.01); A61N 2/02 (2013.01); A61N 5/022 (2013.01); A61N 5/0622 (2013.01); A61B 2562/0219 (2013.01); A61B 2562/0247 (2013.01); A61F 2007/0029 (2013.01); A61F 2007/0039 (2013.01); A61F 2007/0075 (2013.01); A61F 2007/0093 (2013.01); A61F 2007/0095 (2013.01); A61H 23/0263 (2013.01); A61H 39/04 (2013.01); A61H 2201/0207 (2013.01); A61H 2201/0214 (2013.01); A61H 2201/10 (2013.01); A61H 2201/1207 (2013.01); A61H 2201/1635 (2013.01); A61H 2201/164 (2013.01); A61H 2201/165 (2013.01); A61H 2201/5005 (2013.01); A61H 2201/5023 (2013.01); A61H 2201/5084 (2013.01); A61H 2205/06 (2013.01); A61H 2205/10 (2013.01); A61H 2230/00 (2013.01); A61H 2230/06 (2013.01); A61H 2230/50 (2013.01); A61N 1/0456 (2013.01); A61N 1/0484 (2013.01); A61N 1/0551 (2013.01); A61N 1/36034 (2017.07); A61N 1/36067 (2013.01); A61N 2005/0645 (2013.01); A61N 2007/0026 (2013.01); A61N 2007/0095 (2013.01)

Citation (search report)

• [X] US 2017014625 A1 20170119 - ROSENBLUTH KATHRYN H [US], et al
• [XD] WO 2018039458 A1 20180301 - CALA HEALTH INC [US]
• [X] WO 2017044904 A1 20170316 - NALU MEDICAL INC [US]
• [X] US 2018001088 A1 20180104 - TASS PETER ALEXANDER [DE]
• [X] US 2016279435 A1 20160929 - HYDE RODERICK A [US], et al
• [XP] WO 2019046180 A1 20190307 - ADVENTUS VENTURES LLC [US]
• See references of WO 2020006048A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2020006048 A1 20200102; CN 112601488 A 20210402; EP 3813647 A1 20210505; EP 3813647 A4 20220309

DOCDB simple family (application)

US 2019039193 W 20190626; CN 201980055793 A 20190626; EP 19825339 A 20190626